Literature DB >> 7548576

Foot infections in diabetic patients: the role of anaerobes.

D N Gerding1.   

Abstract

The prevalence of anaerobic bacteria in cultures of specimens from foot infections in diabetic patients is dependent upon the method of obtaining the specimen, the care with which it is transported anaerobically, and the sophistication of the laboratory methods. The rate at which anaerobes are isolated with use of the best methods ranges from 74% to 95% of patients, but it is only 41% to 53% in clinical studies of patients with limb-threatening infection. The mean number of bacterial isolates from an infected foot ranges from 4.1 to 5.8, of which 1.2 to 2.6 isolates are anaerobic. Most anaerobic isolates are gram-positive, and Peptostreptococcus species are most common. Bacteroides species are the most common anaerobic gram-negative isolates. Treatment covering anaerobic bacteria is included in most empirical regimens, but the use of agents that are modestly active against anaerobic organisms (i.e., fluoroquinolones or trimethoprim-sulfamethoxazole) has also been successful. Surgical debridement and drainage are essential adjuncts to antimicrobial therapy and may assist in the control of anaerobic infection. Questions regarding management of such infections parallel those regarding management of polymicrobial intraabdominal infections, but to date, studies of the former have been much less sophisticated than those of the latter.

Entities:  

Mesh:

Year:  1995        PMID: 7548576     DOI: 10.1093/clinids/20.supplement_2.s283

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 2.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

3.  Ceftobiprole: First reported experience in osteomyelitis.

Authors:  A Macdonald; G Dow
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Relapse of posttraumatic osteomyelitis due to Clostridium celerecrescens.

Authors:  A Mischnik; S Zimmermann; I Bekeredjian-Ding; M Egermann
Journal:  Infection       Date:  2011-06-07       Impact factor: 3.553

Review 5.  Fluoroquinolone treatment of skin and skin structure infections.

Authors:  A W Karchmer
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

7.  Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Brian J Werth; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  From ulcer to infection: an update on clinical practice and adjunctive treatments of diabetic foot ulcers.

Authors:  C Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

Review 9.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.